The inside cover picture shows the inhibition of multiple HER receptors by unnatural polyketide analogues synthesized by using in vitro precursor-directed chalcone synthase (CHS) catalysis. For further information on how the inhibition of multiple HER receptors has the potential to improve anticance
Unnatural Polyketide Analogues Selectively Target the HER Signaling Pathway in Human Breast Cancer Cells
β Scribed by Seok Joon Kwon; Moon Il Kim; Bosung Ku; Lydie Coulombel; Jin-Hwan Kim; Joseph H. Shawky; Robert J. Linhardt; Jonathan S. Dordick
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 587 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1439-4227
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr
## Abstract Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, __in vitro__ and __in vivo__, __via__ several mechanisms, including
The hormone I ,25-dihydroxyvitamin D3 (VD) has a potential use as an anti-tumor agent, but its clinical applications are restricted by its strong calcemic activity. This has led to the development of VD analogues with selectively increased growthinhibitory activity. One of the most potent analogues